Production (Stage)
ZYUS Life Sciences Corporation
ZLSCF
$0.5046
-$0.0454-8.26%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.53M | -2.87M | -3.52M | -2.48M | -18.00M |
| Total Depreciation and Amortization | 565.80K | 528.60K | 531.30K | 534.80K | 599.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.28M | 203.10K | 146.90K | 155.80K | 14.44M |
| Change in Net Operating Assets | -2.10M | 1.04M | 2.51M | -171.30K | 935.70K |
| Cash from Operations | -3.79M | -1.10M | -323.70K | -1.96M | -2.02M |
| Capital Expenditure | -700.00 | -8.10K | 0.00 | -25.20K | -141.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.34M | -- | -- | -- | -47.00K |
| Cash from Investing | 1.34M | -8.10K | 0.00 | -25.20K | -188.20K |
| Total Debt Issued | 5.00M | 300.00K | 400.00K | -- | 0.00 |
| Total Debt Repaid | -17.00K | -2.60M | -86.00K | -341.00K | -334.00K |
| Issuance of Common Stock | 0.00 | 3.31M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.56M | 744.90K | 229.50K | -252.90K | -245.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.11M | -359.30K | -94.30K | -2.23M | -2.46M |